Theravance Biopharma
TBPH
#6132
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
Theravance Biopharma (TBPH) Fails to deliver data
Key failure to deliver metrics for Theravance Biopharma :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.05 M
- Last 3 months FTD volume: $0.61 M
- Last year FTD volume: $8.34 M
Failures to deliver for Theravance Biopharma (TBPH) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Theravance Biopharma (TBPH) - since 2014
Volume in USD (price x number of shares), data since 2014Theravance Biopharma (TBPH) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.58 M | -93.31% |
| 2023 | $8.8 M | -36.23% |
| 2022 | $13.8 M | 19.02% |
| 2021 | $11.59 M | -91.81% |
| 2020 | $0.14 B | 1644.06% |
| 2019 | $8.11 M | -69.09% |
| 2018 | $26.25 M | -35.11% |
| 2017 | $40.45 M | 100.24% |
| 2016 | $20.2 M | 262.2% |
| 2015 | $5.57 M | -80.57% |
| 2014 | $28.71 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $11.02 M | $17.75 M | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $0.4 M | $1.6 M | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.42 M | $4.04 M | 🇺🇸 USA |
 Catalent CTLT | $24 M | $64.42 M | 🇺🇸 USA |